{"name":"Health Research, Inc.","slug":"health-research-inc","ticker":"","exchange":"","domain":"","description":"Health Research, Inc. is a biotechnology company focused on developing innovative treatment regimens for various medical conditions. The company has two marketed drugs, both of which are regimens designed to improve patient outcomes through optimized treatment protocols.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Experimental Cyclic Regimen","genericName":"Experimental Cyclic Regimen","slug":"experimental-cyclic-regimen","indication":"Atrial fibrillation for stroke prevention","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Standard Clinical Practice Regimen","genericName":"Standard Clinical Practice Regimen","slug":"standard-clinical-practice-regimen","indication":"Major depressive disorder","status":"marketed"}]}],"pipeline":[{"name":"Experimental Cyclic Regimen","genericName":"Experimental Cyclic Regimen","slug":"experimental-cyclic-regimen","phase":"marketed","mechanism":"Experimental Cyclic Regimen works by targeting a specific molecular pathway to modulate cellular behavior.","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""},{"name":"Standard Clinical Practice Regimen","genericName":"Standard Clinical Practice Regimen","slug":"standard-clinical-practice-regimen","phase":"marketed","mechanism":"This drug works by inhibiting the reuptake of serotonin and norepinephrine in the brain.","indications":["Major depressive disorder","Generalized anxiety disorder"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOckEta2RucG5aWGVOaWQ3a3dNLUVVdjloLThkUGdGMnYzSDNob1NmWGM3TlNqMzNqMVJrcnVpbTRtOFp2dXEzcFFXcmp4Q2xIQVdIaWd6am1nQThmZ3FzaFYtODNfMDRJQ1pkWklqOHNDQ20zTHFiaFNGSzJFZFhtNnZqR1pnZU9tRUJZa3BPdUhvSUVUbXc?oc=5","date":"2025-10-27","type":"pipeline","source":"Fort Worth Inc.","summary":"UNT Health Fort Worth College of Pharmacy Ranks Among Top Research Programs in Texas, Nation - Fort Worth Inc.","headline":"UNT Health Fort Worth College of Pharmacy Ranks Among Top Research Programs in Texas, Nation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPWElRTk9IbzVQLXBQa1ZFcXpWa1Nva1VRX3hXN1VzbkpfcXNlRGszdmVLYTd4d1ZyQ3MyR1JfalZ2TVZSV19JMGxiejNrZVFDR3dBNlI5ak9keE5IM1YxM1BiVXIyX1BRSFBxOFMxTm01aGd1WC14VGpmQkV4dXZrV1Z3VU5UVFE4a0I5SFI2VDdsVVd4dG1nbmt6ODZyTGUtVzFsdm42blYwVEVNT19KS243bWNrRjRHcGh1emVVbTNyczk4eVlydTlPYlk?oc=5","date":"2025-09-23","type":"pipeline","source":"The Oklahoman","summary":"OKC to consider $600,000 toward new $46.7 million medical research lab, creating 433 jobs - The Oklahoman","headline":"OKC to consider $600,000 toward new $46.7 million medical research lab, creating 433 jobs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-09-08","type":"trial","source":"PR Newswire","summary":"AMO Pharma Enters into License Agreement with Population Health Research Institute (PHRI) and Venca Research Inc. to Advance Largest-Ever Study in Treatment of Arrhythmogenic Right Ventricular Cardiom","headline":"AMO Pharma Enters into License Agreement with Population Health Research Institute (PHRI) and Venca Research Inc. to Adv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQRkxHQndtV3RMVUxBSlp0eFRaSTV2NHdVOXhfajRhNFRXT3B4cmV1RkZ0Vm01U1Q2S0p0REZoNnUyUXkwOHJNdXJKQmluLUhldVMxWlVzRk9SU1BNSEUyVWs1enFFTmJvZE1QUl92UlFpeW4yTFB3SzZlSlpjM1VLcnlHMHN3a3VvZVcxNTNlaw?oc=5","date":"2025-07-16","type":"pipeline","source":"PwC","summary":"Medical cost trend: Behind the numbers 2026 - PwC","headline":"Medical cost trend: Behind the numbers 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQbEFaQXRRdUxPc1R2dkRaUzlaLWlnLUh3VmlCVFd6TVZRVEVXbU1Nd3dJRXNsa3N5NElyUDhPd0o1ZUZOR0xfVkxyWnBqazlULUNDTXRidVdSLTVfc3cyUGFGNWtOSjI4SkJMTUJ4OFFqZ2VnenpqRzQxQjY0TU5KYmlLRG1IbFhlUmk2V1VORThrY2t6dk9PTk5JNzJTMjYwUWQ2RlRPN01EeWtOWS1xYUZ0R2d1d1ExQmpNcEUtTzh5SlVzbVFlLXhfYlNVbUpHWmVqMVFpeDY3QUtTa2c?oc=5","date":"2025-05-08","type":"pipeline","source":"reuters.com","summary":"Trump administration health research cuts total $1.8 billion, analysis finds - reuters.com","headline":"Trump administration health research cuts total $1.8 billion, analysis finds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNZ1N3Wm5oN01vNjVGYUFjZldBOHVRczdBaGJGRUdYMXlrcTBVc1VJUXlIcEdZTjZrQ05Wb2pxR004X3hTcmNtdXBZaExrN1oxR0ZPRWtqbDFuRTZvVHRfTEpTU1ZUc095TGJJc3NGdG1uVU9Jdm1IRlc3N3RxU1dfdHRsYnJ2SWZLM3lPQVl3aE9Xd0N4N0dkR3RleThIVEF6S1JkR1J6OS1oc3dPZndGNnVjTHFzcTJuS3hlY2JNNFBTTC1lXzNSQTZUd3IyMWZuWGlEYkVHOURxaFAxYmVwMw?oc=5","date":"2025-05-06","type":"pipeline","source":"Purdue University","summary":"Purdue invests in One Health, from making medicines to advancing chemistry, along America’s Hard Tech Corridor - Purdue University","headline":"Purdue invests in One Health, from making medicines to advancing chemistry, along America’s Hard Tech Corridor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNcjFEVGI4Tk9yVWJjTS1ISFk4bjRDeVlrbXMwNVFmU3o1WEd0ZURtNmlGUXFOMEdTdS1OTzZOZTdyMVcxQjQteHFBcmQ2dlYyZEFZanZpWW5GdlJiV3lFNVYwYjhYWXZnSVpVYjU2a0E2U1ZKemFkVkJxQzYyZmsxTVdPSi1sWkhDQjdFX0pYcHBuTTdvSEhFeFJYbmRHUVdjNnFGeGlRcGd2WVdSYWk0dlpQcUVuMG53cDR0bDdUTXFyYkFNSjJVZldweXVDMnZPeGJkR3dlRllDVW1JeUZaR1NtalRnYkQ5MnRLR3hZSzJSeWpTSlBZU044UXVYTlU?oc=5","date":"2025-04-27","type":"pipeline","source":"proactiveinvestors.com","summary":"Recce Pharmaceuticals enters Cooperative Research Agreement with US Army Medical Research Institute - proactiveinvestors.com","headline":"Recce Pharmaceuticals enters Cooperative Research Agreement with US Army Medical Research Institute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOV1JkeFFqOUZjX19HTW1EN3Q5dVlYdFJDdVVlcDkxczE1Y3VlcFBHUk5sTk50TUhmbElQM0lCMUNmMUtkQmVnd0g5ZG5Ud1o0UFNRWWVKMXNxS0FuRndwcy1TSHdtQUc2bHJ4TjZPNUVMajVyS1NzWEplVnhKNlJwOEY4RnctdXhyQ1NOX1hhejMwaTdFNzdmaVE1RnpwLTktMno1YkltTWxRSXY5bm5aTjRuT3pTNHRvekxZSDgzVmtkbkdu?oc=5","date":"2025-04-07","type":"pipeline","source":"Fierce Biotech","summary":"German research institute launches program to match threatened NIH grants with pharma funders - Fierce Biotech","headline":"German research institute launches program to match threatened NIH grants with pharma funders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYU80S2lsM3BnYUh0OE9kYnVRR0dKR2l3b2pVcktXQzhVU2RGMjB3UFU2QVNwQndnb3ZGWXZzXzg1RUdfZXcwb0tBQU5Fd3liQ01HWmR3eVhUUjk5NWxXakNHaTJFSGtKRHN3NEdiVDdFUDkwdnhQSjVKOXdBa2M3RENld0JDVkJPS0F4bWV3RzFMNUpadWFld1ZkcFZ2VWU0WEV3QmM4Q2Q?oc=5","date":"2025-02-10","type":"pipeline","source":"Yale School of Medicine","summary":"Health Care Company Payouts Favor Shareholders, New Research Shows - Yale School of Medicine","headline":"Health Care Company Payouts Favor Shareholders, New Research Shows","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPWDVzV0MtV2ZMc1VjZUNncTk2Y0sxU3NYemhaWS14S1pOQVdvTXNfTHM4U3BQRlRrSXd0YUpudFBpSFR4eGkxSjB1Ykx4QktmVldsYUoyMVlVMkNJVlRRbkpBUGtSRTUyRE5CaEdjRDg3dGhDLVdtRngyeGQ3WUl0OGFR?oc=5","date":"2024-09-09","type":"pipeline","source":"Fierce Pharma","summary":"Mass General Research Institute - Fierce Pharma","headline":"Mass General Research Institute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQNU5vRjJFT0FTbnhTb2plZHJhdmREQVNSMU9VS0k5TzVxUGctenlSdEx0N2VxWXFBelpYUkpTNjlDaTVRdTV2THdITDUwZGt4RVhHMHVkQ3hnZEpEdEp5ZUJKcjBzTGx1cmFwNlo1LS1NOEdmbC1RNnlGNDBMZnUxdTdNeXpNUGMtM1djLV9yUEpmSXg2djd0emFBYlpnNml1dWlvS3pVYkFHcFBZOWdFN01obFdra3JYZHBteWRGZw?oc=5","date":"2024-02-16","type":"trial","source":"dicardiology.com","summary":"AMO Pharma Announces Collaboration with Population Health Research Institute to Advance Proof of Concept Clinical Trial to Assess Efficacy of Tideglusib in Treatment of Arrhythmogenic Cardiomyopathy -","headline":"AMO Pharma Announces Collaboration with Population Health Research Institute to Advance Proof of Concept Clinical Trial ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9WNWIxaW1idkVZQm9ZbHFKNkwwbktTcC1sT0l4X0Y0bHJIZUpDTEU3NDVPakNfV3NEakxkMl96UFEzN2RiTm10S0c3OHBzLWRNUi1iY3d5TzlGcEhoTWhnZG5wQWMxY2Q5ampoT2NIYkxUbFRYMUE?oc=5","date":"2020-11-16","type":"pipeline","source":"Pharma Voice","summary":"Health Consumerism on the Rise - Pharma Voice","headline":"Health Consumerism on the Rise","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}